BIRC5 and breast cancer: It has been shown that BIRC5 is highly expressed in breast cancer, and its expression is correlated with relapse-free survival and overall survival; it, therefore, may have potential as a useful predictive marker and therapeutic target in this context (Dai et al., 2020).